2Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444. patients with coronary heart disease: the Scandinavian Simvastatin Survival Study ( 4S ). Lancet, 1994,344 :1383-1389.
3Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med, 1996,335 : 1001-1009.
4Laufs U, La Fata V, Plutzky J, et al. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation,1998,97 : 1129-1135.
5Thomas M, Mann J. Increased thrombotic vascular events after change of statin. Lancet, 1998,352 : 1830-1831.
6O'Driscoll G, Green D, Taylor RR. Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month.Circulation. 1997,95 : 1126-1131.
7Laufs U, Endres M, Custodis F, et al. Suppression of endothelial nitric oxide production after withdrawal of statin treatment is mediated by negative feedback regulation of rho GTPase gene transcription.Circulation, 2000 , 102:3104-3110.
8Sitzler G, Zolk O, Laufs U, et al. Vascular beta-adrenergic receptor adenylyl cyclase system from renin-transgenic hypertensive rats.Hypertension, 1998,31 : 1157-1165.
9Vecchione C, Brandes RP. Withdrawal of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors elicits oxidative stress and induces endothelial dysfunction in mice. Circ Res, 2002,91:173-179.
10Heeschen C, Harem CW, Laufs U, et al. Platelet Receptor Inhibition in Ischemic Syndrome Management ( PRISM )Investigators. Withdrawal of statins increases event rates in patients with acute coronary syndromes. Circulation,2002 , 105:1446-1452.
